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ABSTRACT 
Background: Opportunistic viral infections can cause considerable morbidity and mortality in organ 
and stem cell transplanted (SCT) patients, mainly due to iatrogenic T cell dysfunction. Whereas in 
SCT patients, in general the immunosuppressive treatment can be discontinued after 6-12 months, for 
the majority of organ transplanted patients, the need for treatment is life-long. 
 Aims: This thesis focuses on infections with cytomegalovirus (CMV), Epstein-Barr virus (EBV), 
adenovirus (AdV) and human herpes virus type 6 (HHV-6) in liver and stem cell transplanted children 
and on the value of quantitative viral DNA measurements. The aims were to (i) investigate the 
incidence and clinical picture of CMV and EBV infection the first year after liver transplantation and 
the usefulness of DNA quantification for identifying these infections, (ii) to compare serum and whole 
blood as material for the analyses and (iii) to describe infections with CMV, EBV, AdV and HHV-6 
and their risk factors, identification and outcome in SCT patients during the first 6-12 months after 
transplantation.  
Methods: Serum samples, drawn the first year after transplantation from 18 liver transplanted children 
were retrospectively investigated for CMV DNA by a quantitative PCR from Roche (CA Monitor), 
and from 24 liver transplanted children for EBV DNA by real time TaqMan PCR. In the comparison 
of sample materials, clinical samples (10,641 for CMV and 2,855 for EBV) drawn mainly from 
transplant patients, were surveyed as regards to viral DNA levels in whole blood and serum. In the 
study of SCT children, serum samples from 47 consecutively transplanted children were 
retrospectively investigated with analysis of viral DNA by TaqMan PCR and related to risk factors in 
a multivariate analysis. 
Results: Any CMV marker was found in 83 % of the liver transplanted patients. Symptomatic 
infection was found in 22% and was associated with significantly higher CMV DNA levels (paper I). 
More than half of the liver transplanted patients in paper II were EBV naïve at transplantation, 
probably due to low median age, but 92 % had markers of EBV infection within 1 year. Symptomatic 
infection was found in 21%: 3 patients with post transplantation lymphoproliferative disease (PTLD) 
and 2 with hepatitis. In these 5 patients, the EBV DNA levels were significantly higher than in the 
patients with asymptomatic infection. In paper III, CMV DNA levels were only 0.2 log higher in WB 
as compared to serum, while EBV DNA levels were 1.5 log higher in WB than in serum. Out of 47 
SCT children (paper IV), 47% developed CMV DNAaemia, 19% at levels > 104 Geq/mL, and 45% 
developed EBV DNAaemia, but only 6 % > 104 Geq/mL. CMV DNAaemia did not develop if neither 
donor nor recipient had CMV IgG. ATG and total body irradiation were independent risk factors for 
high CMV and EBV DNA levels. HHV-6 DNA and AdV DNA were each present in 28% of the SCT 
patients, in the majority in low or moderate levels. Three children died from CMV, EBV and AdV 
complications, representing 21 % of the total mortality after SCT, and all these 3 cases were 
retrospectively found to have very high viral DNA levels in serum.  
Conclusion: Quantification of viral DNA levels contributes to a better basis of understanding of post 
transplant viral infections, and is critical for taking the right actions in terms of balancing 
immunosuppression and antiviral measures. As sample material, serum and whole blood seemed 
equally useful for CMV, while for EBV whole blood was more sensitive but less specific. 
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